Injection site haemorrhage: FDA reporting patterns
78,296 FDA FAERS reports mention Injection site haemorrhage. 10,491 reports have a serious outcome flag.
Medicines named as suspect
- Adalimumab: 17,122 reports
- Etanercept: 8,824 reports
- Exenatide: 7,431 reports
- Tirzepatide: 5,216 reports
- Teriparatide: 4,489 reports
- Evolocumab: 3,990 reports
- Dulaglutide: 3,081 reports
- Interferon Beta-1a: 2,996 reports
- Dupilumab: 1,817 reports
- Galcanezumab: 1,599 reports
- Insulin Glargine: 1,567 reports
- Somatropin: 1,212 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.